Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis
Public ClinicalTrials.gov record NCT03764475. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Open-Label Extension Study of the Long-Term Safety of ARQ-151 Cream 0.3% in Adult Subjects With Chronic Plaque Psoriasis Who Have Completed Preceding Study ARQ-151-201 Phase 2 Randomized Controlled Trial (Cohort 1) and Non-ARQ-151-201 Subjects (Cohort 2)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label, long-term safety study of roflumilast (ARQ-151) 0.3% cream in subjects with chronic plaque psoriasis involving up to 25% total Body Surface Area (BSA). Study medication will be applied by the qualifying subjects topically once daily for 52 weeks at home. Periodic clinic visits will include assessments for clinical safety, application site reactions, and disease improvement or progression.
Study identification
- NCT ID
- NCT03764475
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 332 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 18, 2018 (Actual)
- Primary completion
- Oct 8, 2020 (Actual)
- Completion
- Oct 8, 2020 (Actual)
- Last update posted
- Sep 2, 2022
2018 – 2020
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arcutis Clinical Site 35 | Beverly Hills | California | 90212 | — |
| Arcutis Clinical Site 29 | Northridge | California | 91324 | — |
| Arcutis Clinical Site 28 | San Diego | California | 92123 | — |
| Arcutis Clinical Site 27 | Santa Monica | California | 90403 | — |
| Arcutis Clinical Site 12 | Miami | Florida | 33144 | — |
| Arcutis Clinical Site 16 | Sanford | Florida | 32771 | — |
| Arcutis Clinical Site 21 | Louisville | Kentucky | 40217 | — |
| Arcutis Clinical Site 34 | Clinton Township | Michigan | 48038 | — |
| Arcutis Clinical Site 33 | Detroit | Michigan | 48202 | — |
| Arcutis Clinical Site 20 | Fridley | Minnesota | 55432 | — |
| Arcutis Clinical Site 22 | New York | New York | 10029 | — |
| Arcutis Clinical Site 14 | High Point | North Carolina | 27262 | — |
| Arcutis Clinical Site 39 | Bexley | Ohio | 43209 | — |
| Arcutis Clinical Site 15 | Pittsburgh | Pennsylvania | 15213 | — |
| Arcutis Clinical Site 19 | College Station | Texas | 77845 | — |
| Arcutis Clinical Site 37 | Houston | Texas | 77004 | — |
| Arcutis Clinical Site 13 | Houston | Texas | 77056 | — |
| Arcutis Clinical Site 23 | San Antonio | Texas | 78213 | — |
| Arcutis Clinical Site 24 | Webster | Texas | 77598 | — |
| Arcutis Clinical Site 31 | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03764475, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 2, 2022 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03764475 live on ClinicalTrials.gov.